Follow

First-ever mRNA vaccine halts pancreatic cancer in its tracks

"Importantly, these patients demonstrated delayed recurrence of their pancreatic cancers, providing tantalizing evidence that the T cells activated by the vaccines may be effectively holding the cancer at bay."
thebrighterside.news/post/firs

@estherschindler That's great news, if found safe to give to many people it could be a game changer.

@estherschindler

I wish they'd included the link to the study.

The only thing I saw (after clicking on 20 links that typically just lead back to their own website) was a phase II clinical trial that started recruiting in 2022 & ends in 2029.

Sign in to participate in the conversation

CounterSocial is the first Social Network Platform to take a zero-tolerance stance to hostile nations, bot accounts and trolls who are weaponizing OUR social media platforms and freedoms to engage in influence operations against us. And we're here to counter it.